Try our free ADHD Screening Tool Next available appointment: typically 6 to 8 weeks Book now →
Library guide Co-Occurring Conditions For adults with adhd, depression, or both

ADHD and Depression: Cause, Effect, or Both?

Why depression co-occurs so often with ADHD, what the evidence says about cause and effect, and how UK treatment is sequenced when both are present.

Reviewed 30 May 2025 Next review May 2026 ~1,500 words · 8 min read Clinically reviewed

Depression is one of the most common co-occurring conditions in adults with ADHD. The relationship between the two is rarely simple: depression can be a consequence of unmanaged ADHD, ADHD can be missed when depression is the presenting issue, and both can run independently in the same person. This article covers the prevalence picture, the most useful clinical distinctions, and how treatment is sequenced when both are present.

How often depression and ADHD co-occur

The US National Comorbidity Survey Replication found that around 19 percent of adults with ADHD also met criteria for major depressive disorder in the past year, compared with around 8 percent of adults without ADHD [5]. Lifetime rates are substantially higher; somewhere around half of adults with ADHD will meet criteria for a depressive disorder at some point in their lives [4]. The pattern is replicated across UK and European cohorts.

In children and adolescents, the co-occurrence is also above baseline but lower than in adults. Approximately 15 to 20 percent of children with ADHD meet criteria for a depressive disorder, with the rate climbing across adolescence and into early adulthood [6, 4].

The figures are not artefacts of sampling. They reflect a real and clinically significant overlap.

Why the two travel together

Several mechanisms operate, and most adults with both will have more than one of them in play [4, 6]:

Depression as a downstream consequence of unmanaged ADHD

Living with undiagnosed or unmanaged ADHD generates a steady supply of experiences that produce depression: sustained underperformance relative to ability, repeated job loss or job changes, relationship difficulty, financial chaos, social rejection, and the slow accumulation of a story about oneself as someone who cannot get it together. By the time many adults reach an ADHD assessment, depression is layered on top of years of these experiences. Treating the depression alone often produces partial response because the underlying source of the depressive experiences has not been addressed.

Misdiagnosis of ADHD as depression

ADHD-related difficulties (low motivation, poor concentration, anhedonia in tasks that do not feel rewarding, emotional flatness, sleep disturbance, weight changes) overlap symptomatically with major depression. A person presenting with these features will often be diagnosed with depression first. This is not always wrong; depression and ADHD can coexist. It is wrong when the depression diagnosis closes the door on assessing for ADHD.

Shared biological substrate

Both ADHD and depression involve dopamine and noradrenaline signalling, and both are influenced by stress, sleep and circadian factors. Genetic studies show modest overlap in the risk factors for the two conditions. The shared biology is not the whole story, but it accounts for some of the co-occurrence.

Genuine independent co-occurrence

Sometimes the two are simply both present, each running its own course. ADHD does not protect against depression; depression does not protect against ADHD.

Telling the picture apart

The clinical question is rarely "is this ADHD or depression?" and more usually "which is the leading edge, what does each contribute, and what should be treated first?". A few patterns help [3, 4]:

The childhood pattern

ADHD criteria require onset before age twelve. A pattern of depressive episodes in adulthood without childhood evidence of ADHD-type difficulty argues against underlying ADHD. A childhood and adolescent history of distractibility, disorganisation, task avoidance and emotional dysregulation that pre-dates depressive episodes points the other way.

The texture of the symptoms

Depressive low mood tends to be uniform: persistent across contexts, with anhedonia that affects previously rewarding activities. ADHD-related low mood is more often situational, with intact pleasure in genuinely engaging activities and a return of energy and engagement when the task fits. ADHD-related sleep disturbance tends to be difficulty switching off and delayed sleep onset; depressive sleep disturbance is more often early-morning waking with low mood on waking.

The response to treatment

Adults whose depression has responded partially to standard antidepressant treatment but who continue to struggle with concentration, task initiation and emotional regulation often have underlying ADHD. The phrase "treatment-resistant depression" hides a substantial number of patients with co-occurring undiagnosed ADHD.

The reverse pattern

Some adults receive ADHD treatment first and then notice that depressive symptoms remain even after attention and task initiation improve. In that case, the depression is a separate condition that needs its own treatment.

How treatment is sequenced

NICE NG87 acknowledges co-occurring depression in ADHD and recommends both conditions are addressed [2]. NICE NG222 sets out the standard approach for depression in adults: psychological therapies (CBT, behavioural activation) and pharmacological treatments (SSRIs and others) depending on severity [3]. The sequencing in co-occurring ADHD and depression depends on which is more impairing and on stability.

Severe depression first

Where depression is severe (significant suicidal thinking, marked functional impairment, biological symptoms), depression treatment usually starts first. ADHD assessment and treatment follow once the depressive episode has stabilised.

Mild to moderate depression alongside clear ADHD picture

Where depression is mild to moderate and the ADHD picture is clear (childhood onset, persistent across contexts, clearly causing the everyday difficulties driving the low mood), ADHD treatment may produce useful improvement in both. Many adults find that their depressive symptoms reduce substantially after a period on appropriate ADHD treatment because the underlying cause of the depressive experiences has begun to lift.

Combination treatment

Concurrent treatment of both conditions is common in adults whose presentations include features of both. ADHD medication does not interact with most SSRIs in clinically problematic ways at standard doses, although the prescriber will check for specific interactions (some SSRIs inhibit the enzymes that metabolise atomoxetine, for example, and may warrant dose adjustment) [4].

Bupropion is sometimes mentioned

Bupropion is licensed in the UK for smoking cessation (as Zyban) but is not licensed for either ADHD or depression in the UK. In other countries it is used for both. Some UK clinicians prescribe it off-label where standard options have been exhausted. This is specialist practice and not a default option.

The non-pharmacological picture matters

Sleep, physical exercise, social connection, and structural changes to demand all affect both conditions. ADHD diagnosis is more than medication makes the broader case; the point is particularly relevant where depression is also present.

When the depression is the late-diagnosis pattern

A common adult presentation: years of treatment for depression, partial response, persistent attention and task-initiation difficulty that the patient describes as "depression brain fog" but that does not lift even when mood improves. The childhood history shows ADHD-type difficulties. The eventual ADHD assessment confirms the underlying condition. This pattern is one of the most common reasons adults reach a private adult ADHD assessment.

Practical points for patients

A few notes for adults working through the picture [3, 4]:

  • Treating depression that has responded partially with another antidepressant trial is reasonable, but consider whether ADHD assessment is also warranted, particularly if childhood difficulties were present.
  • Bring the full history to whichever clinician is making the next decision. Old school reports, parental memories, a complete medication history. The pattern only becomes clear with the full picture.
  • Acute suicidal thinking or self-harm is a same-day issue. Use 111, 999, A&E, or the Samaritans on 116 123.
  • ADHD treatment does not "fix" depression. It addresses the ADHD-driven contributors. The depressive condition, if it is present, still needs its own attention.

What this means in practice

  • Around 19 percent of adults with ADHD meet criteria for depression in the past year; lifetime rates are higher.
  • The relationship between the two is multi-causal: depression as a downstream consequence of unmanaged ADHD, misdiagnosis of ADHD as depression, shared biological substrate, and genuine independent co-occurrence.
  • The childhood pattern, the texture of the symptoms, and the response to treatment help disentangle the picture.
  • Treatment usually addresses both, sequenced by which is more impairing.
  • "Treatment-resistant depression" hides a substantial number of adults with co-occurring undiagnosed ADHD.

When to speak to a professional

Speak to your GP if depression has been treated without full resolution and ADHD-type difficulties have been present since childhood. NHS routes for depression and ADHD assessment exist; Right to Choose in England applies to ADHD. NeuroFX offers private ADHD assessment for adults and children aged 6 and upwards, with co-occurring depression considered throughout. Seek urgent help via 111, 999 or A&E for acute suicidal thinking or any mental health crisis. Samaritans: 116 123.

Sources

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022.
  2. NICE. Attention deficit hyperactivity disorder: diagnosis and management. NG87. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng87
  3. NICE. Depression in adults: treatment and management. NG222. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng222
  4. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews. 2021;128:789-818.
  5. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. American Journal of Psychiatry. 2006;163(4):716-723.
  6. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. American Journal of Psychiatry. 1991;148(5):564-577.

References & evidence

Last reviewed 30 May 2025. Next scheduled review: May 2026. Reviewed by Tina Fox, Specialist Neurodevelopmental Practitioner & Independent Prescriber.

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). 2022.
  2. NICE. Attention deficit hyperactivity disorder: diagnosis and management. NG87. https://www.nice.org.uk/guidance/ng87
  3. NICE. Depression in adults: treatment and management. NG222. https://www.nice.org.uk/guidance/ng222
  4. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789-818.
  5. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723.
  6. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991;148(5):564-577.
Tina Fox
Reviewed by

Tina Fox

Specialist Neurodevelopmental Practitioner & Independent Prescriber

Tina is Clinical Lead at NeuroFX, with 15 years of specialist mental health nursing experience and as an advanced specialist paediatric sleep practitioner. She personally leads NeuroFX assessments and prescribing, and clinically reviews the guidance published here against current NICE standards.

Read Tina's full profile →
WhatsApp Call us Book